These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6202901)

  • 41. Successfully treated metachronous liver metastasis of alpha-fetoprotein-producing early gastric cancer: case report.
    Akune S; Saihara T; Ishigami S; Hokita S; Natsugoe S; Aikou T
    Hepatogastroenterology; 2004; 51(57):919-20. PubMed ID: 15143947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Differential diagnosis of AFP-producing chest tumors by tumor markers].
    Ito M; Takashima Y; Chiba W; Miyake M; Taki T; Mitsuoka A; Teramatusu T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Jan; 22(1):26-31. PubMed ID: 6204088
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma].
    Tamura A; Oita T; Sakizono K; Nakajima T; Kasakura S
    Rinsho Byori; 1998 Feb; 46(2):158-62. PubMed ID: 9528340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High alpha-fetoprotein level in HCV-related nodular liver cell dysplasia.
    Ng FH; Chow KC; Cheng CS; Kng C; Ng WF; Wong BC
    Am J Gastroenterol; 1999 Aug; 94(8):2296-7. PubMed ID: 10445567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multimodal application of lectin affinity electrophoresis of alpha-fetoprotein.
    Taketa K
    Electrophoresis; 1998 Jul; 19(10):1774-9. PubMed ID: 9719558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alpha-fetoprotein antibody-lectin enzyme immunoassay to characterize sugar chains for the study of liver diseases.
    Kinoshita N; Suzuki S; Matsuda Y; Taniguchi N
    Clin Chim Acta; 1989 Feb; 179(2):143-51. PubMed ID: 2465850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Early detection of hepatocellular carcinoma with lectin reactive alpha-fetoprotein].
    Matsuyama H; Morishita Y; Nakane K; Fukatsu T; Nakashima N
    Rinsho Byori; 1994 Oct; 42(10):1021-8. PubMed ID: 7527871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of liver tumors in childhood.
    von Schweinitz D
    Semin Pediatr Surg; 2006 Feb; 15(1):17-24. PubMed ID: 16458842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.
    Aoyagi Y; Saitoh A; Suzuki Y; Igarashi K; Oguro M; Yokota T; Mori S; Suda T; Isemura M; Asakura H
    Hepatology; 1993 Jan; 17(1):50-2. PubMed ID: 7678576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Determination of alpha 1 -fetoprotein in internal diseases--current problems].
    Lehmann FG
    Internist (Berl); 1972 Aug; 13(8):332-9. PubMed ID: 4629320
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum copper, ceruloplasmin, protein thiols and thiobarbituric acid reactive substance status in liver cancer associated with elevated levels of alpha-fetoprotein.
    Nayak SB; Yashwanth S; Pinto SM; Bhat VR; Mayya SS
    Indian J Physiol Pharmacol; 2005; 49(3):341-4. PubMed ID: 16440854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Quick detection of alpha-fetoprotein by crossed electrophoresis (author's transl)].
    Pinto Joglar R; Rios E
    Rev Med Chil; 1975 Jan; 103(1):28-9. PubMed ID: 70050
    [No Abstract]   [Full Text] [Related]  

  • 53. alpha-Fetoprotein levels in cirrhosis and cancer of the liver.
    Vilaseca J; Ruibal A; Monne J; Bacardi R; Guardia J
    Br Med J; 1978 Oct; 2(6145):1163. PubMed ID: 81704
    [No Abstract]   [Full Text] [Related]  

  • 54. [The role of tumor markers in the diagnosis and follow-up of liver tumors].
    Ottó S
    Orv Hetil; 2004 Feb; 145(7 Suppl 1):385-7. PubMed ID: 15049057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver hemangiomas and elevated serum α-fetoprotein: unsolved questions.
    Bell D; Kozakewich HP; Fishman SJ; Kulungowski AM; Alomari AI
    Hum Pathol; 2011 Sep; 42(9):1369-71; author reply 1371-2. PubMed ID: 21839297
    [No Abstract]   [Full Text] [Related]  

  • 56. Change in fucosylation of alpha-fetoprotein on malignant transformation of liver cells.
    Aoyagi Y; Isemura M; Suzuki Y; Sekine C; Soga K; Ozaki T; Ichida F
    Lancet; 1986 Jan; 1(8474):210. PubMed ID: 2418321
    [No Abstract]   [Full Text] [Related]  

  • 57. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A; Fraquelli M; Conte D
    Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract]   [Full Text] [Related]  

  • 58. [Analysis of glycoprotein-bound sialic acid in the blood and tissues; with special reference to the fluctuations in liver diseases and liver neoplasms].
    Matsuzaki S; Itakura M; Iwamura K; Kamiguchi H
    Rinsho Byori; 1983 Mar; Suppl 54():175-81. PubMed ID: 6887573
    [No Abstract]   [Full Text] [Related]  

  • 59. [Quick detection of alpha-fetoprotein by crossed electrophoresis (author's transl)].
    Pinto Joglar R; Rios E
    Rev Med Chil; 1975 Jan; 103(1):28-9. PubMed ID: 79205
    [No Abstract]   [Full Text] [Related]  

  • 60. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.